.jpg "Olaf H. Klungel, PharmD, PhD photo")
Head of Division
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Netherlands
Olaf Klungel is Professor of Pharmacoepidemiologic Methods, head of the division of Pharmacoepidemiology & Clinical Pharmacology, and sicentific director of the Utrecht Institute of Pharmaceutical Sciences at Utrecht University. He is also adjunct professor of Pharmacoepidemiology at the University of Southern Denmark in Odense. He was trained as a pharmacist and epidemiologist. His main research area is the development, improvement and evaluation of innovative methods of observational drug research. Main applications are in the post-registration phase of drug development. Prof. Klungel represents the division of Pharmacoemidemiology & Clinical Pharmacology in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), the EU2P steering committee (Director of Benefit/Risk Assessment domain), and is PI of the EU Pharmacoepidemiology & Pharmacovigilance Research Network (formerly PROTECT). He is Past President of the International Society for Pharmacoepidemiology (ISPE) and past elected steering group member of ENCePP. In addition to his research, Prof. Klungel teaches pharmacoepidemiology and pharmacotherapy to medical and pharmacy students. He is (co-)author of over 350 papers in peer reviewed journals, book chapters and research reports.